ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

NCI Approved CTEP Trials For the Month of August

August 31, 2012

QOL With Femara Comparable To Placebo, Analysis Finds

December 26, 2003

Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed

October 8, 1976

Beyond Planned Parenthood: Attendance Flags at Komen Flagship Race, D.C. Participation Drops by Nearly One-Third

June 8, 2012

Also in this 8-page issue: FDA begins search for director of new Office of Oncology Drug Products.

October 8, 2004